BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25132582)

  • 1. Pancreatic stem cells remain unresolved.
    Jiang FX; Morahan G
    Stem Cells Dev; 2014 Dec; 23(23):2803-12. PubMed ID: 25132582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic stem cells: from possible to probable.
    Jiang FX; Morahan G
    Stem Cell Rev Rep; 2012 Sep; 8(3):647-57. PubMed ID: 22090024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to make insulin-producing pancreatic β cells for diabetes treatment.
    Lu J; Xia Q; Zhou Q
    Sci China Life Sci; 2017 Mar; 60(3):239-248. PubMed ID: 27796637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-secreting cells derived from stem cells: clinical perspectives, hypes and hopes.
    Roche E; Reig JA; Campos A; Paredes B; Isaac JR; Lim S; Calne RY; Soria B
    Transpl Immunol; 2005 Dec; 15(2):113-29. PubMed ID: 16412956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells for pancreatic β-cell replacement in diabetes mellitus: actual perspectives.
    Calafiore R; Montanucci P; Basta G
    Curr Opin Organ Transplant; 2014 Apr; 19(2):162-8. PubMed ID: 24553500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An arduous journey from human pluripotent stem cells to functional pancreatic β cells.
    Loo LSW; Lau HH; Jasmen JB; Lim CS; Teo AKK
    Diabetes Obes Metab; 2018 Jan; 20(1):3-13. PubMed ID: 28474496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic stem cells: differentiation options.
    Rao MS; Reddy JK
    Stem Cell Rev; 2005; 1(3):265-71. PubMed ID: 17142864
    [No Abstract]   [Full Text] [Related]  

  • 10. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell applications in diabetes.
    Noguchi H
    J Stem Cells; 2012; 7(4):229-44. PubMed ID: 24196798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting human pluripotent stem cells into beta-cells: recent advances and future challenges.
    Mayhew CN; Wells JM
    Curr Opin Organ Transplant; 2010 Feb; 15(1):54-60. PubMed ID: 19855279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell differentiation: therapeutical challenges in diabetes.
    Roche E; Vicente-Salar N; Arribas M; Paredes B
    J Stem Cells; 2012; 7(4):211-28. PubMed ID: 24196797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose tissue derived stem cells for regeneration and differentiation into insulin-producing cells.
    Kim SC; Han DJ; Lee JY
    Curr Stem Cell Res Ther; 2010 Jun; 5(2):190-4. PubMed ID: 19941446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pluripotent stem cells, a potential source of beta-cells for diabetes therapy.
    Hansson M; Madsen OD
    Curr Opin Investig Drugs; 2010 Apr; 11(4):417-25. PubMed ID: 20336589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro generation of pancreatic β-cells for diabetes treatment. I. β-like cells derived from human pluripotent stem cells.
    Cierpka-Kmiec K; Wronska A; Kmiec Z
    Folia Histochem Cytobiol; 2019; 57(1):1-14. PubMed ID: 30869153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-producing cells derived from stem cells: recent progress and future directions.
    Santana A; Enseñat-Waser R; Arribas MI; Reig JA; Roche E
    J Cell Mol Med; 2006; 10(4):866-83. PubMed ID: 17125591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In search of a surrogate: engineering human beta cell lines for therapy.
    Newby BN; Terada N; Mathews CE
    Trends Endocrinol Metab; 2014 Aug; 25(8):378-80. PubMed ID: 24958526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem-cell therapy, β-cell- and islet cell-neogenesis: possible treatments of type 1 diabetes in the future?].
    Gerő L
    Orv Hetil; 2016 May; 157(19):740-5. PubMed ID: 27133273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
    Vanikar AV; Trivedi HL; Thakkar UG
    Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.